In malaria-endemic areas, adults very rarely succumb to severe malaria, suggesting that immunity to severe disease is life-long under conditions of repeated exposure. To what extent this protection persists in the absence of exposure remains to be established. The aim of this study was to assess whether duration of residency in a malaria-free country affects the risk for severe malaria in immigrants originating from sub-Saharan Africa. We conducted a retrospective chart review of 948 cases of malaria diagnosed in Stockholm, Sweden in 1995-2013. Among 501 adult patients with Plasmodium falciparum (315 of endemic origin and 186 of non-endemic origin, mainly Sweden), 41 (8.2%) had severe malaria according to WHO criteria (including 5% with parasitaemia), 22 (4.4%) had factors prognostic of poor outcome, and 35 (7.0%) were admitted to intensive care. Overall, patient origin did not affect the odds of severe malaria, according to any of these definitions. However, when the immigrants were stratified with regard to their duration of residency in Sweden, the risk of factors prognostic for poor outcome was associated with duration of prior residency in a malaria-free country among patients of endemic origin (p 0.02), and immigrants who had lived for 15 years in Sweden had a similar risk as non-immune travellers. The results of this explorative study suggest that, although immunity to severe malaria is maintained for several years in African adults, this protection might be lost with time without repeated reexposure. A larger study, preferably including multiple centres, will be needed to confirm our findings.
Introduction
Malaria is a potentially life-threatening infection in non-immune individuals [1] . In highly endemic areas, most of which are in sub-Saharan Africa, severe Plasmodium falciparum malaria affects mainly young children, before they gradually acquire clinical protection after repeated infections. In areas of lower transmission and among travellers and migrants from nonendemic areas, individuals of all ages are at risk for severe malaria.
Acquired immunity tends to lower the occurrence of severe malaria faster than that of uncomplicated disease [2] . The low incidence of severe malaria in older children and adults in hightransmission settings suggests that this immunity is life-long under conditions of repeated exposure. However, whether protective immunity to severe malaria is maintained in the absence of re-exposure is debated, with some suggesting that this protection wanes rapidly [2] and others that it persists [3] . Understanding the longevity of immunity against malaria is important for the development of efficacious vaccines and for predictions of populations at risk in areas of changing transmission.
Immigrants originating from malaria-endemic areas in subSaharan Africa and living in malaria-free countries, e.g. in Europe, are at high risk of malaria when returning to malarious areas [4] . Nonetheless, African immigrants are generally recognized to be at lower risk of severe forms of the disease than non-immune travellers [5] [6] [7] [8] [9] [10] . To what extent this protection wanes with time when people are living in non-endemic areas has not been reported.
We conducted a retrospective chart review of malaria cases diagnosed in Stockholm, Sweden, with the aim of assessing whether the risk of severe malaria in African immigrants is affected by the duration of residency in a malaria-free country.
Methods
The study was approved by the Regional Ethical Review Board, Stockholm, Sweden (Drnr 2009/1328-31/5, 2010/1080-32, 2012/1150-32).
Study population
We sought to include all patients diagnosed with malaria in Stockholm, Sweden, between January 1995 and May 2013. Completeness of data was evaluated through comparison with surveillance data at the Public Health Agency of Sweden. The patients were treated at the five hospitals in Stockholm with departments of infectious diseases. The analyses included patients aged 16 years with symptomatic P. falciparum malaria and complete clinical records, and with an origin in sub-Saharan Africa or malaria-free countries. Only the first malaria episode was included for patients with multiple episodes. Patients originating from Asia and other areas with lower transmission were excluded.
Malaria diagnosis
Malaria was diagnosed by microscopy of thick and thin blood films stained with Field's stain. The parasite species was determined in thin films, and occasionally by PCR. Parasitaemia was defined as percentage of infected erythrocytes in thin smears.
Clinical and demographic data
Medical records were reviewed regarding demographics, travel history (including chemoprophylaxis), clinical presentation (signs and laboratory tests), management (admission to hospital and treatment), and disease outcome.
Severe malaria was defined according to: (a) WHO criteria, including 5% cut-offs for hyperparasitaemia [11, 12] ; (b) factors with higher prognostic value for poor outcome [11] ); and (c) admission to the intensive-care unit (ICU). The WHO criteria included at least one of the following: impaired consciousness or unrousable coma (Glasgow Coma Scale 10 (adjusted from [13, 14] ), multiple convulsions, pulmonary oedema, respiratory distress, circulatory collapse (systolic blood pressure of 70 mmHg), abnormal spontaneous bleeding, macroscopic haemoglobinuria, hypoglycaemia (blood glucose level of <2.2 mmol/L), renal failure (serum creatinine level of >265 μmol/L), severe anaemia (haemoglobin level of <5 g/dL), acidosis (pH of <7.25, plasma bicarbonate level of <15 mmol/L, base excess of <10, hyperlactataemia, i.e. lactate level of >5 mmol/L, or when stated in the medical record if laboratory data were missing), and jaundice (bilirubin level of >50 μmol/L) together with evidence of other vital organ dysfunction. Factors with higher prognostic value for poor outcome included impaired consciousness, acidosis, multiple convulsions, circulatory collapse, pulmonary oedema, and/or abnormal bleeding.
Statistical analyses
Analyses were performed with STATA 11.0. The risk of severe malaria was assessed in relation to (a) origin in a malariaendemic country in sub-Saharan Africa, and (b) years of residency in a malaria-free country (including immigrants living for >1 year in Sweden). Chi-squared tests and Fisher's tests were used for categorical variables, the Mann-Whitney U-test for continuous variables, logistic regression for binary outcomes, and linear regression for continuous outcomes. Multivariate modelling was performed to adjust for sex and age, and also chemoprophylaxis usage and patient delay (number of days of symptoms before seeking care).
Results
We identified 948 microbiologically confirmed cases of malaria in Stockholm in 1995-2013, corresponding to 97.8% of cases notified to the Public Health Agency of Sweden. In total, 632 P. falciparum episodes were diagnosed in 601 patients (Fig. 1) , and 501 symptomatic adults were included in the analyses: 186 patients from non-endemic countries (87.1% from Sweden) and 315 patients originating from endemic countries in sub-Saharan Africa (54.8% from West Africa and 36.5% from East Africa, respectively) ( Table 1) .
Among the African immigrants, 39.4% had resided for >10 years in Sweden, and 18.0% had spent <1 year in Sweden (15.8% for <1 month), including temporary visitors and newly arrived migrants, when diagnosed with malaria ( Table 1 ). The majority of immigrants (93.0%) had lived for >10 years in a malaria-endemic country before moving to Sweden. All immigrants, and 87.7% of travellers from non-endemic countries, had visited African countries prior to infection, and 92.1% of the immigrants had visited their countries of origin (Table 1) .
African immigrants were younger, were predominantly male, had lower usage of antimalarial chemoprophylaxis and had a longer time from symptom onset to seeking healthcare than patients from non-endemic areas (all p 0.01) ( Table 1) .
Severe malaria according to WHO criteria was found in 41 (8.2%) patients, 22 (4.4%) had factors prognostic of poor outcome, and 35 (7.0%) were admitted to ICUs. All cases with factors prognostic for poor outcome were included within the WHO criteria 5% definition. Eight patients were admitted to ICUs without fulfilling the WHO criteria 5% definition.
Severity of disease with regard to patient origin and time spent in non-endemic areas An overall comparison between African immigrants and patients of non-endemic origin did not reveal any significant differences in the odds of severe malaria according to any of the definitions, in either unadjusted or adjusted analyses (adjusting for sex and age, and for intake of chemoprophylaxis and patient delay) ( Table 2) .
When the immigrants were stratified with regard to years of residency in a malaria-free country, severe malaria was, overall, less frequent in immigrants who had lived for <10 years in Sweden ( Fig. 2(a) and (c)). Immigrants who had lived in Sweden for 10-14 years and 15 years were similar to travellers of non-endemic origin with regard to severe malaria defined according to WHO criteria (9.7% and 10.0% vs. 9.5%) ( Fig. 2(a) ). Also, admission to ICUs was similar in immigrants who had lived in Sweden for 15 years (9.5%) and patients with non-endemic origin (9.7%) ( Fig. 2(c) ). The effect of years of residency on ICU admission and WHO criteria did not, however, reach statistical significance (all p > 0.05). Interestingly, duration of residency in a malaria-free country was significantly associated with the most severe forms of malaria, i.e. factors prognostic for poor outcomes (p 0.02). Immigrants who had lived in Sweden for 15 years had a similar proportion of severe signs as Swedish travellers and other patients from non-endemic areas (8.1% and 6.5%, respectively) ( Fig. 2(b) ). In contrast, none of the immigrants who had lived in Sweden for 5-14 years had any of these signs, and among patients who has immigrated more recently, four had severe malaria. Unarousable coma was diagnosed in eight patients: four patients of non-endemic origin and four of endemic origin. Three of these had lived in Sweden for 17, 20 and 30 years, and one was a pregnant temporary visitor. There were no in-hospital deaths.
The risk of severe malaria increased gradually after age 40 years in patients from both areas (endemic, p 0.02; nonendemic, p 0.05) (Table 3) . Nonetheless, African immigrants with severe malaria were younger (median, 42 years; range, 21-53 years) than severely ill patients of non-endemic origin (median, 52 years; range, 31-74 years). Chemoprophylaxis usage and patient delay were not associated with severity of disease or ICU admission (all p > 0.15) ( Table 3) .
Patients from non-endemic areas were more often admitted to hospital (92.5% vs. 79.7%, p < 0.001), had longer hospital stays (mean, 3.92 days; 1.72 days longer; unadjusted 95% CI 1.10-2.35) and were more often given intravenous treatment (28.5% vs. 19.7%, p 0.03) than immigrant patients. Nonetheless, when severity of disease was included in an adjusted model, these differences remained, indicating that they were not explained by disease severity (data not shown). 
Discussion
Severe P. falciparum malaria is widely reported to be less frequent in immigrants from sub-Saharan Africa than in nonimmune travellers [5] [6] [7] [8] [9] [10] ; however some authors have not found such differences [16] . Here, using strict definitions of severity, we did not detect any significant overall differences in severe malaria between these groups. However, when the immigrants were stratified with regard to duration of residency in Sweden, we found an effect of duration on the most severe forms of malaria. The results suggest that, although immunity to severe malaria is maintained for several years, this protection might be lost without repeated re-exposure.
We compared individuals from sub-Saharan Africa, where P. falciparum malaria is highly endemic, with travellers from Sweden or other malaria-free countries. Country of origin is, of course, a crude marker of malaria exposure and pre-existing immunity, and transmission intensity often varies greatly within countries [1] . African immigrants who have lived in Sweden for only a few years are likely to represent the background level of immunity in the heterogeneous population with different histories of exposure. Only a few cases of severe malaria were recorded among immigrants residing for between 1 and 10 years in Sweden, and although various patterns were noted, the majority of severe cases were recorded in patients with longer residency.
Numerous studies have compared immigrants and nonimmune travellers, with different designs and definitions of severe malaria. Bouchaud et al. described a lower risk of severe malaria in immigrants living in France for a median of 14 years; however, severity of disease was not reported in relation to the number of years in a malaria-free country [6] . Another study performed over different periods reported severe malaria only in immigrants residing for 13-19 years in Italy [17] . A high risk of severe malaria has also been reported in newly arrived migrants (mainly severe anaemia) [8] . Also, in our study some severe signs of malaria were detected in newly arrived Africans, perhaps because of factors related to recent migration. The analysis of severity in relation to time of residency was therefore restricted to immigrants who had lived for at least 1 year in Sweden.
The risk of severe malaria was assessed according to different definitions. With the WHO criteria, including a 5% threshold for hyperparasitaemia, we found a tendency for there to be more severe malaria in immigrants who had lived in Sweden for >10 years. The parasitaemia 5% threshold does not, however, always correlate with severity [18] , and hyperparasitaemia is no longer stated as an individual parameter in the recently updated WHO guidelines for management of severe malaria [19] . Admission to an ICU undoubtedly reflects severe disease; however, the criteria for ICU admission might have varied in different hospitals and over time. We therefore considered factors prognostic for poor outcome to constitute the most robust marker of severe malaria. Although restrictive, this definition of outright complicated malaria best predicted an increased risk of severe malaria in long-term residents. Moreover, frequency of admission to hospital, frequency of intravenous treatment and length of hospital stay were all lower in African immigrants; however, not all of these were explained by severity of disease. Differences in length of hospital stay might reflect faster clearance of symptoms [6] , but might also represent the patient's own desire not to stay in the hospital or the physician's fear of more severe disease in non-immune travellers. These factors are thus not as stringent predictors of severity as specific clinical signs.
Fatal outcome is obviously the most severe marker of disease. Interestingly, no deaths were recorded among patients diagnosed with malaria in Stockholm in 1995-2013. The casefatality rates in patients with P. falciparum malaria in nonendemic areas have been reported to be 0.3-1.3% overall [5, 7, 20, 21] , 0-0.9% in immigrants (reviewed in [22] ), and 0.6-3% in non-immune travellers [7, 20] . The case-fatality rate was substantially higher in areas in the UK where malaria diagnosis was uncommon [20] , and doctors' delay was reported in fatal cases in Switzerland [23] . In Stockholm, the acute management of fever in patients returning from tropical areas is centralized to specialist physicians in infectious diseases with prompt access to malaria diagnostics and care, which might have contributed to the favourable outcome.
Old age has been identified as a risk factor for severe malaria in travellers [24, 25] . Gradually increased risk with age after 40 years was observed, irrespective of origin. The immigrants with severe malaria were younger than the Swedish travellers also reflected by different age profiles in the two groups (Table 1) . Adjustments for age were not possible within the respective strata for duration of residency, and a larger study would be needed for more detailed analyses of age in relation to time without re-exposure.
Host genetic factors, including sickle-cell traits and other haemoglobinopathies, are common in African populations, and may explain the reduced risk for severe malaria in the immigrant group [9] . Although genetic factors are likely to contribute to protection, they could not explain the changing risk with time in immigrants observed in our study.
An understanding of the mechanisms by which immunity to severe malaria is acquired and maintained would be highly valuable for vaccine development. Antibodies are well recognized to constitute an important component of malaria immunity; however, antibodies against P. falciparum antigens have been reported to be short-lived [26] . There is now growing evidence that, despite a lack of circulating antibodies, P. falciparum-specific memory B-cells are also long-lived in travellers [27] , and higher antibody levels after an episode of acute malaria in immigrants suggest activation of immunological memory [6] . Further studies are needed to identify the immune responses involved in immunity to severe malaria in relation to longevity of protection.
The changing epidemiology over the last decade has resulted in targets being set for malaria elimination in several countries [1] . Reducing transmission might change the age patterns of infections, with older children being at risk for severe malaria [28] . Moreover, formerly immune individuals might lose immunity, unless they are repeatedly infected or chronically parasitized [29] . In the highlands of Madagascar, where malaria re-emerged after efficacious control for 30 years, older adults were less likely to contract malaria (severity not reported) [30] . The longevity of immunity against severe malaria has, to our knowledge, not been reported in epidemiological studies, and we believe that the approach of studying travellers can contribute valuable information.
Limitations of the study are inherent in the retrospective study design; for eaxmple, reliable information about the frequency of visits to malarious areas was not available. Systematic collection of data in a prospective study is preferable; such a study would not, however, be possible in a single centre such as Stockholm. Although we included all cases of malaria over nearly two decades, the number of cases restricted in-depth subgroup analyses with regard to years without exposure. A larger study, preferably including multiple centres, will be needed to confirm the validity of our findings.
In conclusion, the results from this explorative study indicate that the risk of severe malaria in African immigrants is affected by duration of residency in a malaria-free country. If confirmed, the findings challenge the notion that immunity to severe malaria is life-long without re-exposure, and identifies a group of patients who might deserve special attention in the management of malaria.
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